CC(=O)OC1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4Cc5cnn(-c6ccc(F)cc6)c5N[C@@]4(C)CC[C@@H]32)C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?